Renal Health Models in Latin America: Development of National Programs of Renal Health

Depine, Santos Ángel; Calderón, Rafael Burgos

doi:10.1080/08860220600925743

Cited by 10 publications

(9 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of chronic kidney disease and end-stage renal disease whether related to high BP or other causes is largely unknown across Latin America because these conditions are underdiagnosed [Zatz et al 2003]. In a recent workshop involving various Latin American health ministries, scientific and medical societies, and PAHO, it was noted that the true prevalence of kidney disease in Latin America is unknown [Depine and Calderon, 2006].…”

Section: Renal Diseasementioning

confidence: 99%

“…In Latin America, chronic kidney disease usually is caused by diabetes, high BP, or glomerulonephritis [Depine and Calderon, 2006]. The profile of renal pathology appears to be somewhat different in Latin America than in other countries; most notably, the rate of glomerulonephritis is higher in Latin America because of tropical parasitic diseases [Zatz et al 2003].…”

Section: Renal Diseasementioning

confidence: 99%

See 1 more Smart Citation

High blood pressure in Latin America: a call to action

Rubinstein

Alcocer

Chagas

2009

Therapeutic Advances in Cardiovascular Disease

View full text Add to dashboard Cite

High blood pressure (BP) is an enormous global problem, and is especially challenging for low-and middle-income countries such as those of Latin America. Although developed countries have benefited from significant reductions in cardiovascular and cerebrovascular disease in recent decades, comparable reductions have not been achieved in Latin America. In fact, the prevalence of high BP is increasing in many Latin American countries, and the situation will worsen without definitive efforts to correct it. The growing preponderance of hypertension and chronic diseases, coupled with expected increases in population growth, present a mounting threat to Latin American economies. This report provides a comprehensive overview of the burden of high BP throughout Latin America, and presents recommendations for change. The dismal observations warrant a call to action for improved control of high BP and other cardiovascular risk factors across Latin America. Achieving these ambitious goals will require collaborative efforts by many groups, including policymakers, international organizations, healthcare providers, schools and society as a whole.

show abstract

Section: Renal Diseasementioning

confidence: 99%

Section: Renal Diseasementioning

confidence: 99%

High blood pressure in Latin America: a call to action

Rubinstein

Alcocer

Chagas

2009

Therapeutic Advances in Cardiovascular Disease

View full text Add to dashboard Cite

show abstract

“…The general and specific objectives, implementation, main strategies for generalization and the preliminary results of the pilot program have recently been published [27]. The program was planned and designed by the Uruguayan Society of Nephrology [28] according to the Latin American Society of Nephrology and Hypertension [20,21,22,23,24,25,26,27,28,29,30] and the recommendations of the consensus workshops of the International Society of Nephrology [31], and is supported by the National Resource Fund and the Public Health Ministry.…”

Section: Introductionmentioning

confidence: 99%

Improving the Management of Chronic Kidney Disease in Uruguay: A National Renal Healthcare Program

Schwedt¹,

Solá²,

Ríos³

et al. 2009

Nephron Clin Pract

View full text Add to dashboard Cite

Background: Uruguay has implemented a chronic kidney disease (CKD) prevention program. Aims: The objectives of the study are to assess the results of the National Renal Healthcare Program (NRHP). Methods: This study is a cohort study of nondialysis-registered patients from October 2004 to March 2008. We made a comparison between patients under nephrology care (NC) or the care of a primary care physician (PCP; prereferral). In the outcome analysis, the primary endpoint was end-stage renal disease (ESRD) and the secondary endpoints were progression of CKD, compliance with the therapeutic goals and death. ESRD/mortality predictors were determined by Cox analysis. Results: The study comprised 2,219 patients aged 67.4 ± 13.5 years, of whom 52.5% were male, 42.1% hypertensive, 16.9% had diabetic nephropathy, and 61.3 and 21.4% were in CKD stages III and IV, respectively. At baseline, NC patients showed a better control than patients under the care of a PCP: systolic blood pressure ≧160 mm Hg (22.4 vs. 31.1%); total cholesterol <5.8 mmol/l (56.6 vs. 42.5%); and low-density lipoprotein cholesterol <2.9 mmol/l (41.2 vs. 29.1%). Control improved in patients under the care of a PCP according to years of enrollment. Outcome analysis (1,188 patients) showed a significant improvement in targets, with 56% of the patients stabilizing. CKD stage IV, diabetic nephropathy, proteinuria and hypertension increased the risk of ESRD; angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and age <65 years decreased the risk. Conclusions: Our results highlight the best management of CKD patients in both groups and the impact of the NC and renin-angiotensin-aldosterone system blockers.

show abstract

“…Renal aggressors, facilitated by the inhospitable environment in which vulnerable individuals work, highlight the multicausal aspect of disease development, facilitated by existing inequalities in Latin America and the Caribbean [ 6]. Many years have passed since international efforts and consensus aimed at managing the problem of CKD and its solutions have been published [ 7,8], including a specific proposal for Latin America in 2005 [ 9,10]. In 2012, KDIGO published an update to the guides with a new classification that included albuminuria, thus establishing a gradient of complexity and risk between this variable and the glomerular filtration rate (GFR) [ 11].…”

Section: Introductionmentioning

confidence: 99%

Population Kidney Health. A New Paradigm for Chronic Kidney Disease Management

Calderón¹,

Depine²,

Martínez³

2021

Preprint

Self Cite

View full text Add to dashboard Cite

Statistical data extracted from national databases demonstrate a continuous growth in the incidence and prevalence of chronic kidney disease (CKD) and the ineffectiveness of current policies and strategies based on individual risk factors to reduce them, as well as their mortality and costs. Some innovative programs, telemedicine and government interest in the prevention of CKD, did not facilitate timely access to care, continuing the increased demand for dialysis and transplants, high morbidity and long-term disability. In contrast, new forms of kidney disease of unknown etiology affected populations in developing countries and underrepresented minorities, who face socioeconomic and cultural disadvantages. With this background, we analyze in the existing literature the effects of social determinants in CKD, concluding that it is necessary to strengthen current kidney health strategies, designing in a transdisciplinary way, a model that considers demographic characteristics integrated into individual risk factors and risk factors population, incorporating the population health perspective in public health policies to improve results in kidney health care, since CKD continues to be an important and growing contributor to chronic diseases.

show abstract

Renal Health Models in Latin America: Development of National Programs of Renal Health

Cited by 10 publications

References 8 publications

High blood pressure in Latin America: a call to action

High blood pressure in Latin America: a call to action

Improving the Management of Chronic Kidney Disease in Uruguay: A National Renal Healthcare Program

Population Kidney Health. A New Paradigm for Chronic Kidney Disease Management

Contact Info

Product

Resources

About